journal article·2025-04Open access

Intranasal delivery of AEP inhibitor-loaded neuron-targeted liposome ameliorates radiation-induced brain injury

Keman Liao, Yan Gao, Mengdan Cheng, Yibing Zhang, Jianyi Zhao, Li Zhou, Ran Wu, Gang Cai, Lu Cao, Jiayi Chen, Yingying Lin

Abstract

Acute exposure to high-dose radiation during head and neck tumors radiotherapy can result in radiation-induced brain injury (RIBI), characterized by neurocognitive deficits, dementia, and epilepsy. Asparagine endopeptidase (AEP), a cysteine proteinase, is effective in preventing neurodegenerative diseases and RIBI. However, the limited permeability of selective AEP inhibitor (AEPI) delivery to the brain reduces its effectiveness in preventing RIBI. This study constructed a nose-to-brain delivery platform for AEPI by encapsulating it in liposomes that are surface modified with rabies virus glycoprotein (RVG29), creating RVG29-AEPI liposomes. These RVG29-AEPI liposomes demonstrated efficient cellular uptake and blood-brain barrier penetration in vitro and in vivo . RVG29-AEPI liposomes effectively shielded DNA from radiation-induced damage and resulted in more effective reactive oxygen species removal than liposomes in primary neurons and microglial cells. Notably, the treatment with RVG29-AEPI liposomes (10 mg/kg AEPI) was highly systemically safe and significantly reduced brain injury. Behavioral tests demonstrated that RVG29-AEPI liposomes-treated mice had less radiation-induced brain damage and motor dysfunction. Moreover, it significantly prevented neuronal injury and microglia cell activation under photon and modern proton irradiation. These findings demonstrate the potential of nose-to-brain medication delivery of RVG29-AEPI liposomes for effective radioprotection, indicating a viable technique with enormous potential for clinical translation. Highlights • RVG29-AEPI liposomes enhanced BBB penetration and cellular uptake in vitro and in vivo. • Nose-to-brain delivery of RVG29-AEPI liposomes showed effective radioprotection. • RVG29-AEPI liposomes reduced DNA damage, ROS, and neuronal injury post-radiation. • Treatment with RVG29-AEPI liposomes was safe and improved motor function.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Anesthesia and Neurotoxicity Research · Vagus Nerve Stimulation Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (29)

Show source-provided references
1. Cerebral radiation necrosis: incidence, pathogenesis, diagnostic challenges, and future opportunities10.1007/s11912-019-0818-y ↗
2. Radiation-induced redox alteration in the mouse brain10.1016/j.freeradbiomed.2019.08.020 ↗
3. Prospective analysis of radiation-induced contrast enhancement and health-related quality of life after proton therapy for central nervous system and skull base tumors10.1016/j.ijrobp.2024.01.007 ↗
4. Efficacy and safety of apatinib for radiation-induced brain injury among patients with head and neck cancer: an open-label, single-arm, phase 2 study10.1016/j.ijrobp.2022.03.027 ↗
5. A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury10.1126/scitranslmed.abm6543 ↗
6. Concurrent olaparib and radiation therapy in older patients with newly diagnosed glioblastoma: the phase 1 dose-escalation PARADIGM trial10.1016/j.ijrobp.2024.01.011 ↗
7. Stem-cell therapy as a potential strategy for radiation-induced brain injury10.1007/s12015-020-09984-7 ↗
8. Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury10.1016/j.ymthe.2021.06.019 ↗
9. Asparagine endopeptidase deficiency mitigates radiation-induced brain injury by suppressing microglia-mediated neuronal senescence10.1016/j.isci.2024.109698 ↗
10. Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer's disease in mice10.1038/s41386-023-01774-2 ↗
11. Discovery of orally available and brain penetrant AEP inhibitors10.1021/acs.jmedchem.3c01804 ↗
12. Spinal cord injury-activated C/EBPbeta-AEP axis mediates cognitive impairment through APP C586/Tau N368 fragments spreading10.1016/j.pneurobio.2023.102467 ↗
13. Role of asparagine endopeptidase in mediating wild-type p53 inactivation of glioblastoma
14. Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling10.1186/s13046-022-02411-4 ↗
15. AEP-cleaved DDX3X induces alternative RNA splicing events to mediate cancer cell adaptation in harsh microenvironments10.1172/JCI173299 ↗
16. Beyond traditional sunscreens: a review of liposomal-based systems for photoprotection10.3390/pharmaceutics16050661 ↗
17. Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-synuclein aggregation and improve behavioral symptoms in Parkinson's disease
18. A mix & act liposomes of phospholipase A2-phosphatidylserine for acute brain detoxification by blood‒brain barrier selective-opening10.1016/j.apsb.2023.11.015 ↗
19. A fast-acting brain-targeted nano-delivery system with ultra-simple structure for brain emergency poisoning rescue10.1039/D2NR05093E ↗
20. Trojan horse delivery of 4,4'-dimethoxychalcone for parkinsonian neuroprotection10.1002/advs.202004555 ↗
21. Is the acetylcholine receptor a rabies virus receptor?10.1126/science.7053569 ↗
22. Contemporary radiotherapy: present and future10.1016/S0140-6736(21)00233-6 ↗
23. The impact of high and low dose ionising radiation on the central nervous system10.1016/j.redox.2016.08.002 ↗
24. Microglia as therapeutic target for radiation-induced brain injury10.3390/ijms23158286 ↗
25. Mitochondrial respiration in microglia is essential for response to demyelinating injury but not proliferation10.1038/s42255-024-01080-1 ↗
26. Microglia drive transient insult-induced brain injury by chemotactic recruitment of CD8+ T lymphocytes10.1016/j.neuron.2022.12.009 ↗
27. Pregabalin mitigates microglial activation and neuronal injury by inhibiting HMGB1 signaling pathway in radiation-induced brain injury10.1186/s12974-022-02596-7 ↗
28. Initiation of Parkinson's disease from gut to brain by δ-secretase10.1038/s41422-019-0241-9 ↗
29. Mitochondrial dysfunction triggers the pathogenesis of Parkinson's disease in neuronal C/EBPβ transgenic mice10.1038/s41380-021-01284-x ↗